Skip to main content

Table 1 Characteristics of the 452 patients with three 2D shear wave elastography (SWE) measurements

From: 2D-shear wave elastography: number of acquisitions can be reduced according to clinical setting

 

N = 452

Age (years) ± SD (missing N = 29)

49.0 ± 13.5

Gender M/F (missing N = 18)

282(65%)/152(35%)

BMI (kg/m2) ± SD (missing N = 201)

26.3 ± 5.6

< 25 kg/m2

115 (46%)

25–29.9 kg/m2

81 (32%)

≥ 30 kg/m2

55 (22%)

ALD

62 (14%)

HBV

108 (24%)

HCV

116 (26%)

NAFLD

69 (15%)

Other

97 (21%)

2D-SWE registration—Biopsy delay (days) median (IQR)

0 (0; 2)

Mean LS of three 2D-SWE measures (kPa) median (IQR)

9 (6.8; 21.4)

Fibrosis stage

 F0

72 (15.9%)

 F1

103 (22.8%)

 F2

72 (15.9%)

 F3

54 (12.0%)

 F4

151 (33.4%)

Steatosis grade (missing N = 149)

 S0

140 (46%)

 S1

82 (27%)

 S2

60 (20%)

 S3

21 (7%)

AST (IU/L) (missing N = 55) median (IQR)

48 (32; 69)

ALT (IU/L) (missing N = 36) median (IQR)

52 (32; 85)

Total bilirubin (µmol/L) (missing N = 48) median (IQR)

13 (8.6; 23.9)

  1. 2D-SWE two dimensional—shear wave elastography, ALD alcohol-related liver disease, AST aspartate aminotransferase, BMI body mass index, CLD chronic liver disease, HBV hepatitis B virus, HCV hepatitis C virus, IQR interquartile range, LS liver stiffness, NAFLD nonalcoholic fatty liver disease, SD standard deviation. Data are expressed as numbers (%), means (SD) or medians (IQR) as appropriate